NCT05758714

Brief Summary

The primary project objective is to investigate how an individual's choices influence personal exposures to traffic-related air pollutants (TRAPs) and the corresponding acute health effects. TRAPs are a complex mixture of particulate and gaseous pollutants that vary considerably spatially and temporally. There is increasing evidence that TRAPs inflict a broad range of deleterious health effects in both health-compromised and healthy individuals, and it has been reported that traffic pollutants may cause up to half of all air pollution-related mortalities. Despite the burden from such widespread, involuntary exposures, few studies have examined the magnitude of personal exposures due to commuting exposures. Most commuters travel to and from work during two peak travel periods, which occur during weekday mornings and evenings. Public transportation, bicycling, and walking have been promoted as ways to reduce air pollution by reducing the vehicle fleet, yet few studies have examined how exposures are modified due to an intentional change in the time of commute or the subsequent health effects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 6, 2023

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

February 15, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 7, 2023

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 14, 2025

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 24, 2025

Completed
Last Updated

June 11, 2025

Status Verified

June 1, 2025

Enrollment Period

2.2 years

First QC Date

February 15, 2023

Last Update Submit

June 10, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • Blood Pressure measurements before and after the sampling period

    Systolic and Diastolic measured on the non-dominant arm

    Collected pre and post each 48-hour sampling period of each participant (4 measurements per participant). Participants will complete all measurements within one season.

  • Changes in FEV1 (Spirometry)

    FEV is short for forced expiratory volume. FEV1 is the amount of air you can force from your lungs in one second. It's measured during a spirometry test, also known as a pulmonary function test, which involves forcefully breathing out into a mouthpiece connected to a spirometer machine.

    Collected pre and post each 48-hour sampling period; also collected after each commute (8 measurements per participant). Participants will complete all measurements within one season.

  • Changes in FVC (Spirometry)

    Forced vital capacity (FVC) is the total amount of air exhaled during the FEV test. Forced expiratory volume and forced vital capacity are lung function tests that are measured during spirometry.

    Collected pre and post each 48-hour sampling period; also collected after each commute (8 measurements per participant). Participants will complete all measurements within one season.

  • Exhaled Nitric Oxide before and after sampling period

    Identifies airway inflammation

    Collected pre and post each 48-hour sampling period (4 measurements per participant). Participants will complete all measurements within one season.

  • Presence of urinary biomarkers of exposures to polycyclic aromatic hydrocarbons (PAHs) and nitro-PAHs (nPAHs) in urine

    Urinary biomarkers of PAHs and nPAHs exposures can be utilized to evaluate systemic inflammation.

    Collected after each 48-hour sampling period (2 measurements per participant). Participants will complete all measurements within one season.

Study Arms (1)

Hartford Commuters

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study will include 65 working adults (age 18 years and over) who live in Hartford County, CT. Both males and females will be recruited into the study. The study will include all racial/ethnic groups for this study in an attempt to be representative of the Hartford population.

Must be YES to qualify 1. Do you live or work in Hartford County? 2. Do you normally commute for more than 20 minutes in the morning? 3. Does your normal route to work include a heavily trafficked road? 4. Can you work outside your home for at least 2 days in a row during the sampling week? 5. You will be asked to commute to work by car for two days between 6:30-8:30 am (during rush hour) and outside of the rush hours (before or after that time range) on two different days of the study. You may be the passenger or driver during the commute. Is this something you are willing and able to do? 6. Are you willing and able to complete questionnaires/ surveys in English by text message or email? 7. Do you have access to e-mail? 8. Are you 18 years or older? Must be NO to qualify 1. Are you currently pregnant? 2. Do you smoke? 3. Do you have usual exposure to environmental tobacco smoke? 4. Have you been diagnosed with a chronic lung disease, such as COPD or asthma? Must not have an episode/exacerbation within the last six months 5. Are you currently taking hypertension medications?

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

UConn Health

Farmington, Connecticut, 06030, United States

Location

Study Officials

  • Misti L Zamora, PhD

    UConn Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 15, 2023

First Posted

March 7, 2023

Study Start

February 6, 2023

Primary Completion

April 14, 2025

Study Completion

April 24, 2025

Last Updated

June 11, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations